Traduction de «dans la women » (Français → Néerlandais) :

Biopsy rates are higher among women aged 70 to 79 years (12.2 per 1000 women per screening round) than among younger women. As expected, the number of screen detectedd cancer is highest in this age group.
As expected, the number of screen detectedd cancer is highest in this age group.

Table 22 : Evolution of interventions in time amongst women 40 - 49 (Belgium) per 100 000 women (2002-2008).
Table 22: Evolution of interventions in time amongst women 40 - 49 (Belgium) per 100 000 women (2002-2008).

Table 20 : Invasive breast cancer and in situ breast cancer amongst women aged 40-49, observed and estimated incidence rate / 100.000 women per year in Flanders (Belgium) (1999-2006)
Table 20: Invasive breast cancer and in situ breast cancer amongst women aged 40-49, observed and estimated incidence rate / 100.000 women per year in Flanders (Belgium) (1999-2006)

Middle trimester, perinatal death rate: In white women (n = 10,074): – without proteinuria and < 90 mmHg = 15.2 – without proteinuria and º 90 mmHg = 25.8 – with proteinuria and < 90 mmHg = 38.5 – with proteinuria and º 90 mmHg = 17.0 In black women (n = 2880): – without proteinuria
perinatal death rate: In white women (n = 10,074): – without proteinuria and < 90 mmHg = 15.2 – without proteinuria and º 90 mmHg = 25.8 – with proteinuria and < 90 mmHg = 38.5 – with proteinuria and º 90 mmHg = 17.0 In black women (n = 2880): – without proteinuria and < 90 mmHg = 20.3 – without proteinuria and º 90 mmHg = 34.6 – with proteinuria and 90 mmHg = 56.6 – with proteinuria and º 90 mmHg = 142.9

Brigham and Women's Hospital: Brigham and Women's Hospital (Boston) - Hospital/Medical Center; 2001 [cited January 2005].
The Royal New Zealand college of General Practitioners: The Royal New zealand college of General Practitioners; 1999 [cited January 2005].

screening round). Conversely, false-negative mammography results are a little more common among women aged 70 to 79 years (1.5 per 1000 women per screening round).
Rates of additional imaging are relatively low among women aged 70 to 79 years (64.03 per 1000 women per screening round).

Les études randomisées (HERS, Women’s Health Initiative) ne montrent pas cette augmentation de risque, bien qu’une augmentation non statistiquement significative ait été observée dans la Women’s Health Initiative.
De gerandomiseerde studies (HERS, Women’s Health Initiative) tonen deze toename niet, alhoewel de Women’s Health Initiative een niet-statistisch significante toename laat zien.

- La Women’s Health Initiative Memory Study est une subdivision de la Women’s Health Initiative.
- De Women’s Health Initiative Memory Study is een substudie van de Women’s Health Initiative.

Additional diagnostic tests Rates of additional imaging are relatively low among women aged 70 to 79 years (64.03 per 1000 women per screening round).
Biopsy rates are higher among women aged 70 to 79 years (12.2 per 1000 women per screening round) than among younger women.

- La Women’s Health Initiative (WHI), réalisée chez des femmes ménopausées en bonne santé: chez les femmes non hystérectomisées, avec l’association d’estrogènes conjugués (0,625 mg p.j) et d’AMP (2,5 mg p.j.), chez les femmes hystérectomisées, avec des estrogènes conjugués seuls (0,625 mg p.j.).
- De Women’s Health Initiative (WHI) bij gezonde postmenopauzale vrouwen: bij de vrouwen met baarmoeder ter plaatse over de combinatie van geconjugeerde oestrogenen (0,625 mg p.d) en MPA (2,5 mg p.d.), bij de vrouwen die hysterectomie hadden ondergaan over geconjugeerde oestrogenen alleen (0,625 mg p.d.).